Patents by Inventor Scott T. Chadwick

Scott T. Chadwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7205402
    Abstract: The present invention provides novel methods for the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (III) which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.
    Type: Grant
    Filed: September 1, 2005
    Date of Patent: April 17, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Purushotham Vemishetti, Scott T. Chadwick, Carrie A. Costello, Sridhar Desikan, Emily A. Reiff
  • Patent number: 7012158
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of ?-difluoromethylornithine (DFMO) having the formula
    Type: Grant
    Filed: February 26, 2004
    Date of Patent: March 14, 2006
    Assignee: Skinmedica, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti
  • Publication number: 20040171876
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of &agr;-difluoromethylornithine (DFMO) having the formula 1
    Type: Application
    Filed: February 26, 2004
    Publication date: September 2, 2004
    Applicants: Bristol-Myers Squibb Company, Bristol-Myers Squibb Company to Women First Healthcare, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti
  • Patent number: 6730809
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of &agr;-difluoromethylornithine (DFMO) having the formula
    Type: Grant
    Filed: August 19, 2002
    Date of Patent: May 4, 2004
    Assignee: Women First Healthcare, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti
  • Publication number: 20030083384
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of &agr;-difluoromethylornithine (DFMO) having the formula 1
    Type: Application
    Filed: August 19, 2002
    Publication date: May 1, 2003
    Applicant: Bristol-Myers Squibb Company to Women First HealthCare, Inc.
    Inventors: Jingyang Zhu, Scott T. Chadwick, Benjamin A. Price, Shannon X. Zhao, Carrie A. Costello, Purushotham Vemishetti